Article

Retinal camera receives 510(k) clearance

A digital nonmydriatic retinal camera (CR-2 Plus, Canon U.S.A., Inc.) has received 510(k) clearance from the FDA and is available for purchase through authorized dealers.

Lake Success, NY-A digital nonmydriatic retinal camera (CR-2 Plus, Canon U.S.A., Inc.) has received 510(k) clearance from the FDA and is available for purchase through authorized dealers.

The action brings the company “one step closer to improving eye exam efficiency and eventually leading to the early prevention and treatment of vision-threatening diseases,” said Tsuneo Imai, senior director and general manager of the medical systems division of Canon U.S.A.
The camera enables fundus autofluorescence photography in a non-mydriatic mode that monitors macular waste materials and delivers both red-free and cobalt digital filters to aid in evaluating the vascular and nerve fiber layers. The device also includes 18 megapixel autofocus technology and low-flash intensity, designed to minimize pupil constriction while shortening the time required for taking multiple pictures. Additionally, its software (Retinal Imaging Control Software, Canon) allows images to be captured, processed, and sent as digital files to a permanent storage database or printed through compatible equipment.

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.